BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim SH, Baek KH. Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect. Int J Mol Sci 2021;22:6173. [PMID: 34201062 DOI: 10.3390/ijms22126173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kotha A, Madu C, Lu Y. Perspective Chapter: Impact of Tumor Metabolism on Immune Cells in the Tumor Microenvironment. Tumor Microenvironment - New Insights [Working Title] 2023. [DOI: 10.5772/intechopen.108830] [Reference Citation Analysis]
2 Yang YF, Li CH, Cai HY, Lin BS, Kim CH, Chang YC. Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis. Int J Mol Sci 2022;23. [PMID: 36555470 DOI: 10.3390/ijms232415831] [Reference Citation Analysis]
3 Ding Y, Ye B, Sun Z, Mao Z, Wang W. Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer Therapy. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200077] [Reference Citation Analysis]
4 Choi H, Lim E, Baek K. Deubiquitinating Enzyme USP12 Regulates the Pro-Apoptosis Protein Bax. IJMS 2022;23:13107. [DOI: 10.3390/ijms232113107] [Reference Citation Analysis]
5 Ragab EM, El Gamal DM, Mohamed TM, Khamis AA. Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma. Eur J Med Res 2022;27:172. [PMID: 36076266 DOI: 10.1186/s40001-022-00803-y] [Reference Citation Analysis]
6 Ragab EM, Gamal DME, Mohamed TM, Khamis AA. Impairment of electron transport chain and induction of apoptosis by chrysin nanoparticles targeting succinate-ubiquinone oxidoreductase in pancreatic and lung cancer cells.. [DOI: 10.21203/rs.3.rs-1949376/v1] [Reference Citation Analysis]
7 Park HB, Hwang S, Baek KH. USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma. Cell Death Dis 2022;13:698. [PMID: 35948545 DOI: 10.1038/s41419-022-05136-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Caba C, Mohammadzadeh A, Tong Y. On the Study of Deubiquitinases: Using the Right Tools for the Job. Biomolecules 2022;12:703. [DOI: 10.3390/biom12050703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Park H, Baek K. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Park SS, Baek KH. Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins. Int J Mol Sci 2022;23:514. [PMID: 35008940 DOI: 10.3390/ijms23010514] [Reference Citation Analysis]
11 Yunusova N, Kolegova E, Sereda E, Kolomiets L, Villert A, Patysheva M, Rekeda I, Grigor'eva A, Tarabanovskaya N, Kondakova I, Tamkovich S. Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome. Molecules 2021;26:6965. [PMID: 34834058 DOI: 10.3390/molecules26226965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Stuelten CH, Zhang YE. Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment. Front Cell Dev Biol 2021;9:764727. [PMID: 34712672 DOI: 10.3389/fcell.2021.764727] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Tatekawa S, Ofusa K, Chijimatsu R, Vecchione A, Tamari K, Ogawa K, Ishii H. Methylosystem for Cancer Sieging Strategy. Cancers (Basel) 2021;13:5088. [PMID: 34680237 DOI: 10.3390/cancers13205088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sun X, Zhao P, Li H, Liu Y, Wang T, Cheng Y. Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer. J Oncol 2021;2021:9715154. [PMID: 34608390 DOI: 10.1155/2021/9715154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]